Pähler, Axel
F. Hoffmann-La Roche AG
3 papers on CoChat
Most cited papers
- Verified
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease
Völkel, W., Sicilia, T., Pähler, A., Gsell, W., Tatschner, T., Jellinger, K., Leblhuber, F., Riederer, P., Lutz, W. K., & Götz, M. E. (2006) · Neurochemistry International
Alzheimer's disease research and treatmentsAntioxidant Activity and Oxidative Stress
Cited by 76
- Verified
Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2-Chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1 H -imidazol-4-ylethynyl]pyridine (Basimglurant, RO4917523), a Promising Novel Medicine for Psychiatric Diseases
Jaeschke, G., Kolczewski, S., Spooren, W., Vieira, E., Bitter-Stoll, N., Boissin, P., Borroni, E., Büttelmann, B., Ceccarelli, S., Clemann, N., et al. (2015) · Journal of Medicinal Chemistry
Neuroscience and Neuropharmacology ResearchTreatment of Major Depression
Cited by 66
- Verified
Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design
Brink, A., Pähler, A., Funk, C., Schuler, F., & Schadt, S. (2017) · Drug Discovery Today
Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free